134 related articles for article (PubMed ID: 28735113)
21. Neutron spectra around a tandem linear accelerator in the generation of (18)F with a bonner sphere spectrometer.
Lagares JI; Araque JE; Méndez-Villafañe R; Arce P; Sansaloni F; Vela O; Díaz C; Campo X; Pérez JM
Appl Radiat Isot; 2016 Aug; 114():154-8. PubMed ID: 27235889
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the neutron radiation field with activation foils and intermittent irradiations around a PETtrace biomedical cyclotron.
Benavente-Castillo JA; Lacerda MAS; Ferreira AV; Dalle HM; Da Silva TA
Appl Radiat Isot; 2019 Nov; 153():108823. PubMed ID: 31400649
[TBL] [Abstract][Full Text] [Related]
23. Radioactive by-products of a self-shielded cyclotron and the liquid target system for F-18 routine production.
Kambali I; Suryanto H; Parwanto
Australas Phys Eng Sci Med; 2016 Jun; 39(2):403-12. PubMed ID: 26867652
[TBL] [Abstract][Full Text] [Related]
24. Monte Carlo neutron doses estimations inside a PET cyclotron vault room.
Barquero R; Méndez R; Martí-Climent JM; Quincoces G
Radiat Prot Dosimetry; 2007; 126(1-4):477-81. PubMed ID: 17504752
[TBL] [Abstract][Full Text] [Related]
25. Proton range monitoring with in-beam PET: Monte Carlo activity predictions and comparison with cyclotron data.
Kraan AC; Battistoni G; Belcari N; Camarlinghi N; Cirrone GA; Cuttone G; Ferretti S; Ferrari A; Pirrone G; Romano F; Sala P; Sportelli G; Straub K; Tramontana A; Del Guerra A; Rosso V
Phys Med; 2014 Jul; 30(5):559-69. PubMed ID: 24786664
[TBL] [Abstract][Full Text] [Related]
26. Modeling of a Cyclotron Target for the Production of 11C with Geant4.
Chiappiniello A; Zagni F; Infantino A; Vichi S; Cicoria G; Morigi MP; Marengo M
Curr Radiopharm; 2018; 11(2):92-99. PubMed ID: 29651945
[TBL] [Abstract][Full Text] [Related]
27. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
[TBL] [Abstract][Full Text] [Related]
28. Benchmark experiments for cyclotron-based neutron source for BNCT.
Yonai S; Itoga T; Baba M; Nakamura T; Yokobori H; Tahara Y
Appl Radiat Isot; 2004 Nov; 61(5):997-1001. PubMed ID: 15308182
[TBL] [Abstract][Full Text] [Related]
29. A novel experimental approach to characterize neutron fields at high- and low-energy particle accelerators.
Braccini S; Casolaro P; Dellepiane G; Mateu I; Mercolli L; Pola A; Rastelli D; Scampoli P
Sci Rep; 2022 Oct; 12(1):16886. PubMed ID: 36207394
[TBL] [Abstract][Full Text] [Related]
30. GEANT4 simulation of cyclotron radioisotope production in a solid target.
Poignant F; Penfold S; Asp J; Takhar P; Jackson P
Phys Med; 2016 May; 32(5):728-34. PubMed ID: 27155937
[TBL] [Abstract][Full Text] [Related]
31. Experimental verification of beam characteristics for cyclotron-based epithermal neutron source (C-BENS).
Tanaka H; Sakurai Y; Suzuki M; Masunaga S; Mitsumoto T; Fujita K; Kashino G; Kinashi Y; Liu Y; Takada M; Ono K; Maruhashi A
Appl Radiat Isot; 2011 Dec; 69(12):1642-5. PubMed ID: 21463945
[TBL] [Abstract][Full Text] [Related]
32. Improvement of dose distribution in phantom by using epithermal neutron source based on the Be(p,n) reaction using a 30 MeV proton cyclotron accelerator.
Tanaka H; Sakurai Y; Suzuki M; Takata T; Masunaga S; Kinashi Y; Kashino G; Liu Y; Mitsumoto T; Yajima S; Tsutsui H; Takada M; Maruhashi A; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S258-61. PubMed ID: 19376720
[TBL] [Abstract][Full Text] [Related]
33. Modification of the University of Washington Neutron Radiotherapy Facility for optimization of neutron capture enhanced fast-neutron therapy.
Nigg DW; Wemple CA; Risler R; Hartwell JK; Harker YD; Laramore GE
Med Phys; 2000 Feb; 27(2):359-67. PubMed ID: 10718140
[TBL] [Abstract][Full Text] [Related]
34. Development, design, and testing of a microwave-driven compact rotating-target D-D fast neutron generator for imaging applications.
Kromer H; Adams R; Prasser HM
Appl Radiat Isot; 2021 Aug; 174():109715. PubMed ID: 33930728
[TBL] [Abstract][Full Text] [Related]
35. Neutron flux characterisation of the Pavia TRIGA Mark II research reactor for radiobiological and microdosimetric applications.
Alloni D; Prata M; Salvini A; Ottolenghi A
Radiat Prot Dosimetry; 2015 Sep; 166(1-4):261-5. PubMed ID: 25958412
[TBL] [Abstract][Full Text] [Related]
36. Analytical shielding calculations for a proton therapy facility.
Avery S; Ainsley C; Maughan R; McDonough J
Radiat Prot Dosimetry; 2008; 131(2):167-79. PubMed ID: 18487617
[TBL] [Abstract][Full Text] [Related]
37. Low-cost target system for neutron activation using a medical cyclotron. Application to the non-destructive analysis of gold and silver.
Campbell M; Tikka A
Appl Radiat Isot; 2022 Jun; 184():110117. PubMed ID: 35272232
[TBL] [Abstract][Full Text] [Related]
38. Neutron yield and induced radioactivity: a study of 235-MeV proton and 3-GeV electron accelerators.
Hsu YC; Lai BL; Sheu RJ
Radiat Prot Dosimetry; 2016 Jan; 168(1):124-33. PubMed ID: 25628454
[TBL] [Abstract][Full Text] [Related]
39. Identification of Activation Isotopes in a CS-30 Cyclotron Vault.
Abuhoza AA; Kassim HA; Alghamdi AA; Alrumayan FM; Arib M; Aljammaz IJ; ALQahtani M
Sensors (Basel); 2022 Mar; 22(7):. PubMed ID: 35408196
[TBL] [Abstract][Full Text] [Related]
40. A scintillator-based approach to monitor secondary neutron production during proton therapy.
Clarke SD; Pryser E; Wieger BM; Pozzi SA; Haelg RA; Bashkirov VA; Schulte RW
Med Phys; 2016 Nov; 43(11):5915. PubMed ID: 27806590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
